1. Home
  2. TMC vs DAWN Comparison

TMC vs DAWN Comparison

Compare TMC & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TMC the metals company Inc.

TMC

TMC the metals company Inc.

N/A

Current Price

$6.40

Market Cap

2.6B

ML Signal

N/A

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

N/A

Current Price

$21.26

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TMC
DAWN
Founded
2011
2018
Country
Canada
United States
Employees
47
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TMC
DAWN
Price
$6.40
$21.26
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
$9.42
$26.61
AVG Volume (30 Days)
3.9M
5.3M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
N/A
$53.52
Revenue Next Year
N/A
$27.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.60
52 Week Low
$1.57
$5.64
52 Week High
$11.35
$21.40

Technical Indicators

Market Signals
Indicator
TMC
DAWN
Relative Strength Index (RSI) 50.20 82.01
Support Level $6.19 $6.40
Resistance Level $6.64 N/A
Average True Range (ATR) 0.36 0.63
MACD 0.06 1.18
Stochastic Oscillator 78.18 98.73

Price Performance

Historical Comparison
TMC
DAWN

About TMC TMC the metals company Inc.

TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: